Minji Kim

Entrepreneur in Residence at Formation Bio

Speaker

Minji is a biotech executive and dealmaker with more than 20 years of experience across corporate and business development, strategy, operations, and cross-border company building. She has held leadership roles at Curis, Jounce Therapeutics, Mineralys Therapeutics, and AffaMed Therapeutics—where she led high-impact transactions and built global operations across the U.S., Europe, and Asia. Her transaction experience spans over a few billion dollars in total value across licensing, equity investment, M&A, joint venture and clinical collaborations. Minji has expertise in oncology, immunology, ophthalmology, CNS, cardiovascular, and digital therapeutics, and has led both in- and out-licensing from early discovery to late-stage clinical assets.

Minji is currently an Entrepreneur-in-Residence at Formation Bio, an AI tech-driven drug development company in the US, and leading NewCo creation efforts by in-licensing high-potential assets from the APAC region. She is also the Founder of Cross Border Partners, LLC, advising biotech and startups, and currently serves on the Board of SK Biopharmaceuticals, a commercial stage global biopharmaceutical company. Minji holds a Ph.D. in Molecular and Cell Biology from Seoul National University and an MBA in Finance and Strategy from Yale School of Management. Prior to starting her industry career at Roche, she was an instructor of Neurology at Harvard Medical School.